The humoral immune respnses of NIH Swiss and SWR/J mice immunized with formalin-inactivated AKR or Gross murine leukemia virus, respectively, were examined. Both immune sera had high titers of antibodies detectable in radioimmune precipitation assays using [3H]leucine-labeled AKR virus and in radioimmunoassays using purified virion components. The predominant antibody titers were directed against gp7l and pl5(E) The immune response against gp7W was predominantly type-specific, whereas the reactivity with p15(E) was predominantly group-specific. A (15, 16) . Furthermore, the immune response was relatively weak and, in general, the titers of precipitating antibodies were significantly lower than the naturally occurring antibodies to the endogenous MuLV.
predominantly type-specific, whereas the reactivity with p15(E) was predominantly group-specific. A weak immune response against p15 was also detected. Both sera were cytotoxic against cells replicating the AKR-Gross virus type but not against cells replicating Friend murine leukemia virus. This cytotoxicity could be specifically blocked with purified gp7l of AKR murine leukemia virus. Sera from immune NIH Swiss mice neutralized AKR virus, but did not neutralize Rauscher, Scripps, or wild mouse leukemia virus.
Ecotropic murine leukemia viruses (MuLV) are endogenous to various inbred strains of mice and have been etiologically linked to spontaneous and radiation-induced thymic lymphomas in these mice (1, 2) . Although the regulation of expression of these viruses is complex and involves various genetic factors, one component of this regulation is the ability to mount a systemic humoral immune response to the virus (3) (4) (5) . This autogenous immune response has been examined in various strains of mice and, in general, is characterized by precipitating antibodies to the envelope components gp7l, gp43, and p15(E) of the virus (5) (6) (7) (8) . The natural immunological reactivities appear type-specific against the major glycoprotein, gp7l, reacting only with the gp7l of AKR MuLV and not with gp7l of Rauscher or Friend MuLV. In contrast, natural antibodies have group specificity against p15(E) and via this crossreactivity precipitate Rauscher or Friend MuLV (7, 9) . The efficacy of this immune response in regulating pathogenesis is not totally understood, although the ability of this response to neutralize infectious virus (Ihle et al., unpublished) and to be cytotoxic against virus-replicating cells suggests a beneficial function (10) . Clearly, however, experiments designed to alter this immune response are warranted.
Several investigators have examined the effect of virus immunization in mice (11) (12) (13) ; however, the characteristics of the immune response were not determined. More (15, 16) . Furthermore, the immune response was relatively weak and, in general, the titers of precipitating antibodies were significantly lower than the naturally occurring antibodies to the endogenous MuLV.
The present experiments were undertaken to examine, quantitatively and qualitatively, the humoral immune response of mice to immunization with formalinized virus vaccines to better correlate any protective effects with specific immunological reactions. The results demonstrate that of the techniques tested for immunization to date, this protocol induced the strongest humoral immune response, and that, in general, the qualitative parameters of this immune response are similar to those of the autogenous immune response.
MATERIALS AND METHODS
Test Sera. Sera were generally separated by centrifugation at 400 X g for 15 min and were stored at -70°. All sera were heat-inactivated at 560 for 30 min.
Immunization. Weanling MAI-NIH Swiss female mice were inoculated with freshly banded formalin-treated AKR virus vaccine with equal parts of complete Freund's adjuvant. Sera were collected on day 87 and were tested for complement fixation, neutralization, and viral precipitation activity. SWR/J male mice were inoculated with freshly banded formalintreated Gross Radioimmune Precipitation Assay Against Intact Virus. The radioimmune precipitation assay against intact radioactively labeled AKR virus has been described (3).
To prepare immune precipitates for polyacrylamide gel electrophoresis, 0.025-0.050 ml of serum was allowed to react with 2 X 105 cpm of Triton-disrupted virus and subsequently precipitated with antiserum against mouse immunoglobulin as described (5) . The precipitates were resuspended in 0.05 ml of 1% sodium dodecyl sulfate (NaDodSO4), 1% 2-mercaptoethanol in 0.01 M sodium phosphate buffer at pH 7.4; incubated at 60°for 1 hr; and finally, incubated at 370 overnight.
NaDodSO4-Polyacrylamide Gel Electrophoresis of Immune Precipitates. The electrophoresis was performed as described by Weber and Osborn (19) . The gels were sectioned into 1-mm slices, and dissolved overnight in 30% hydrogen peroxide at 75°. The radioactivity of each gel-slice fraction was determined with a liquid scintillation counter.
Virus Proteins. The glycoprotein (gp7l) and the major internal protein (p30) from AKR and Rauscher MuLV were purified as described (6) . Other AKR MuLV structural proteins, plO, p12, and p15, were purified with virions disrupted by lithium diiodosalicylate by Sephadex G-200 and DEAE-Sephadex chromatography (Ihle et al., in preparation). Antigens were iodinated as described (6) . The reactivity is also observed with autogenous immune sera and has been shown to be due to the immune response to p15(E) (7), a virion envelope component shared by MuLV (20, 21) . As demonstrated below, NIH Swiss and SWR/J immune sera have similar crossreactive antibodies to p15(E) that account for the above results, and consequently the reactivity with Rauscher or Moloney MuLV provides a relative measure of the titer against p15(E).
The antigenic specificity of this immune response was examined by reacting immune and control sera with disrupted [3H]leucine-labeled AKR MuLV virions and analyzing the immune precipitates by NaDodSO4-polyacrylamide gel electrophoresis as described (5) . As demonstrated in Fig. 2 immune sera reacted with comparable virion components as detected by this assay. The predominant reactivities appeared to be with components migrating in the positions of gp7l and p15(E), which are similar to the reactivities seen with most autogenous immune sera as described (5) and as shown here for comparison in Fig. 2C . In contrast, however, neither serum precipitated significant amounts of gp43. In addition, both immune sera precipitated material migrating slightly faster than p15(E), as well as a minor peak migrating somewhat more slowly than p15(E). Control sera from NIH Swiss and SWR/j mice only weakly reacted in this assay. The reactivity of these sera with purified MuLV components was also examined. Typical titrations are shown in Fig. 3 and the results are summarized in Table 2 . Both groups of immune sera had high titers of antibody capable of precipitating AKR MuLV gp7l in direct radioimmunoassay. In contrast, these immune sera had only low titers of antibodies capable of reacting with Rauscher MuLV gp7l, demonstrating that the Radioimmunoassays were performed as described in Materials and Methods using iodinated purified virion components. The specific radioactivities of the antigens were between 1 and 3 x 104 cpm/ng, and generally 1-2 ng were used per assay. Titers are expressed as the serum dilution giving 50% of maximum precipitation of each antigen.
immune response to gp7l was predominantly type-specific. These results are not unexpected since recent studies have demonstrated significant differences in the serological relationship of these glycoproteins (6) . Immune sera did not react with p30 from Rauscher or AKR MuLV nor with plO or p12 of the AKR virus. These results are in agreement with the NaDodSO4-polyacrylamide gel electrophoresis profiles of the immune precipitates. However, although not clearly detected by the NaDodSO4-polyacrylamide gel electrophoresis profiles, both sera had a low but significant titer against p15. This reaction has also been previously detected by gel diffusion reactions of AKR p15 with similar immune sera (22) . This antigen is serologically unique from p15(E) and migrates on gels slightly faster than p15(E). The other AKR MuLV antigens, gp43 and p15(E), were not available for comparable analysis. Nevertheless, the results taken together demonstrate that the pre- dominant titers of these immune sera are against gp7l and p15(E), although the relative titer of the latter can only be inferred from the reactivity with Rauscher or Moloney MuLV.
The efficacy of this immune response was examined by determining the ability of these sera to be cytotoxic against various virus-replicating cells. As demonstrated in Table 3 , sera from either strain, at a time when high radioimmune precipitation titers were present, were significantly cytotoxic against AKR and RL61 cells. These sera, however, were not cytotoxic against the Friend MuLV-producing cell line Eveline. These results are in agreement with the type specificity of the immune response to the glycoprotein. The antigenic specificity of this cytotoxicity is demonstrated in Table 4 . The cytotoxicity of immune sera from NIH Swiss mice against AKR cells could be completely blocked by prior inoculation with AKR MuLV gp7l. As above, the type specificity of this immune response is demonstrated by the inability of gp7l from Rauscher MuLV to give comparable blocking. These results, therefore, demonstrate that these sera are cytotoxic and type-specific and that this cytotoxicity and its specificity are due to the characteristics of the immune response to AKR MuLV gp7l.
The ability of these sera to neutralize various MuLV is illustrated in Table 5 . Immune sera from NIH Swiss mice neutralized AKR MuLV but did not neutralize Rauscher or other MuLVs. Since significant neutralization has only been associated with an immune response to gp71 (23, 24) and not with p15(E) (9), these results are compatible with the radioimmunoassay data, which demonstrate a type-specific response to the glycoprotein. DISCUSSION The experiments reported here were undertaken to characterize the immune response of mice to immunization with formalinized virus vaccines. The most evident consequence of such immunizations was the induction of a relatively strong immune response as determined by a number of parameters, including radioimmune precipitation assays, radioimmunoassays against the AKR MuLV gp7l, cytotoxicity, and neutralization. The response is quantitatively stronger than the majority of autogenous immune sera from various inbred strains of mice (3) (4) (5) and is approximately 100-to 500-fold higher than the immune response induced in BALB/c and C57BL/6 mice immunized against Friend MuLV gp7l (15-17). Furthermore, in our experience, this response is considerably stronger than that obtained by immunization with tumor cells or nonformalinized virus vaccines.
The response was in part characterized by high titers of predominantly type-specific antibodies against the AKR MuLV gp7l. The type specificity of the immune response of mice to MuLV glycoproteins has been a consistent characteristic observed in autogenous immune sera (6, 7) and in immune sera from mice immunized with tumor cells (unpublished). This response was not unexpected, however, since recent results (6) have demonstrated that distinct serological differences exist between purified gp7l from AKR MuLV and Friend or Rauscher MuLV, even in terms of heterologous antisera against the purified glycoproteins. The consequences of this type specificity, however, are extremely important in any consideration of immunoprophylaxis, since gp7l recognition is important in virus neutralization and, as demonstrated here, in cytotoxicity. Thus, as has been evident in previous reports (15) (16) (17) , immunization for protection will require the appropriate viral preparation or glycoprotein of the virus under study. A strong humoral immune response was also detected against p15(E), an antigen also recognized in an autogenous immune response. This immune response is predominantly group-specific and is the basis of the crossreactivity of these sera with Rauscher or Moloney MuLV (7). These results are compatible with the observation that p15(E) is a common virion envelope component of murine C-type viruses, which has predominantly group-and interspecies-serological characteristics. The consequences of an immune response to p15(E) are not known, although xenogeneic antisera to p15(E) only weakly neutralizes the virus (25) .
The only additional immune response detectable was a weaker reaction with AKR MuLV p15. This antigen is unique from p15(E) and migrates slightly faster than p15(E) on NaDodSO4-polyacrylamide gel electrophoresis. In addition, p15 is a type-specific antigen. The reaction of similar immune sera with purified AKR MuLV p15 has also been previously detected by gel diffusion (22) and in this study was demonstrated to be type-specific. The consequences of an immune response to p15 are unknown, although with the availability of the purified antigen and specific antisera, this question can be approached.
The combined results demonstrate that immunization with formalinized virus vaccines can induce a strong humoral immune response. The characteristics of this response in vitro (i.e., neutralization and cytotoxicity) clearly suggest that such immunizations can be efficacious in controlling viral burdens in vivo and possibly in controlling pathogenesis. Examination of this question directly in vivo should provide definitive results to assess the usefulness of virus vaccines in controlling endogenous virus-mediated pathogenesis.
